Sunshine Biopharma prices $6.0 million public offering

Sunshine Biopharma Inc. priced a public offering of 10,909,083 units at $0.55 per unit for expected gross proceeds of approximately $6.0M. Each unit includes one share (or pre-funded warrant) and two Series D warrants exercisable at $0.66.Material DetailsContext by AI AnalystThis follows a common m…